The largest database of trusted experimental protocols

Methocel e5 premium lv

Manufactured by Dow
Sourced in Germany, United States

Methocel E5 Premium LV is a hydroxypropyl methylcellulose (HPMC) product manufactured by Dow. It is a fine, white to off-white powder used as an excipient in pharmaceutical and other applications. Methocel E5 Premium LV functions as a binder, film former, and viscosity-increasing agent.

Automatically generated - may contain errors

3 protocols using methocel e5 premium lv

1

HPMC Inks for Haloperidol Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hydroxypropyl methylcellulose (HPMC) inks with polymer contents of 12–18% were prepared as placebo formulations. HPMC (Methocel E5 Premium LV, Dow, Bomlitz, Germany) was dissolved in a deionized water and ethanol (Etax Aa 99.5%, Altia Oyj, Rajamäki, Finland) solvent mixture (1:1, v/v) using high speed mixing. Glycerol (CAS 200-289-5, Fagron GmbH & Co. KG, Glinde, Germany) (1%) was used as a plasticizer. Erythrosin B (spirit soluble 95%, CAS 16423-68-0, Aldrich Chem. Co., Milwaukee, WI, USA) was added (1%, v/w) as colorant to the formulations. Formulation development was continued with the formulation that contained 16% of HPMC. Lactic acid (LA, 1%, v/w) (CAS 50-21-5, Sigma-Aldrich, Japan), was added to the 1:1 ethanol water solvent mixture to lower the pH and consequently allow haloperidol (HAL, CAS 52-86-8, Sigma, China) to dissolve. Table 1 lists the various combinations of ink formulations that were studied.
+ Open protocol
+ Expand
2

Tesevatinib Salt Characterization and Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tosylate salt of tesevatinib [N-(3,4-dichloro-2-fluorophenyl)-7-((((3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)-methyl)-oxy)-6-(methyloxy)quinazolin-4-amine] was obtained from Kadmon Corporation (New York, NY) and used for all experiments (purity >98%). The chemical structure of tesevatinib (XL647) has been previously reported (13 (link)). The molecular weights of the tosylate salt and the free base are 663.59 g/mol and 491.14 g/mol, respectively. All dosing and concentrations reported here are with respect to tesevatinib free base. Erlotinib was obtained from the National Cancer Institute. For in vitro studies, tesevatinib and erlotinib were dissolved in DMSO and stored at −20 °C. For in vivo studies, tesevatinib was suspended in 0.5% METHOCEL™ E5 premium LV (DOW, Midland, MI) and 0.2% Tween 20 (Bio-Rad, Hercules, CA) in phosphate buffered saline (PBS) and administered by oral gavage. Erlotinib was suspended in 0.5% METHOCEL™ E5 premium LV in PBS and administered by oral gavage. Analytical-grade reagents (for LC-MS/MS analysis), and a 96-well rapid equilibrium dialysis (RED) base plate and membrane inserts (8 kDa molecular weight cut-off cellulose dialysis membrane) were purchased from Thermo Fisher Scientific (Waltham, MA).
+ Open protocol
+ Expand
3

Taste-Masking Coated Warfarin Pellets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Warfarin sodium clathrate (batch # WA22003; Alchymars Icm SM Private Ltd., Tamil, Nadu, India) was used as an active pharmaceutical ingredient. Microcrystalline cellulose (MCC) spheroids (CELPHERE™ CP-507 (500–710 µm); Asahi Kasei Co., Tokyo, Japan), dibasic calcium phosphate anhydrous (80 wt.%) and microcrystalline cellulose (20 wt.%) spheroids (PharSQ® Spheres M (500–710 µm); Budenheim KG, Budenheim, Germany) [25 (link),26 ], and sodium chloride (NaCl; Valdo SIA, Riga, Latvia) sieved particles (500–800 µm fraction) were used as cores of pellets. Hydroxypropyl methylcellulose (HPMC; Methocel™ E5 premium LV; Dow Chemical, Midland, MI, USA) was used as a binder for drug loading (Figure 1A). Co-polymer comprising methyl methacrylate (MMA) and diethylaminoehtylmethacrylate (DEAEMA) in the ratio 7:3 in the form of aqueous dispersion Kollicoat® Smartseal 30D (BASF SE, Ludwigshafen, Germany) was used as a taste-masking coating material (Figure 1B) [27 ] and dibutyl sebacate (DBS; Merck KGaA, Darmstadt, Germany) as a plasticiser [28 ]. A synthetic colloidal silicon dioxide (Syloid® 244FP; Grace GmbH, Worms, Germany) was used as anti-tacking/-caking agent. Hydrochloric acid (37%), potassium dihydrogen phosphate, and disodium hydrogen phosphate (analytical grade) were supplied by Merck KGaA (Darmstadt, Germany).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!